Tevogen Cash from 2010 to 2025
| TVGN Stock | 1.14 0.03 2.56% |
Cash | First Reported 2010-12-31 | Previous Quarter 8 K | Current Value 7.6 K | Quarterly Volatility 3.2 M |
Check Tevogen Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tevogen Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 160.5 K, Interest Expense of 227.9 K or Selling General Administrative of 1.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Tevogen financial statements analysis is a perfect complement when working with Tevogen Bio Valuation or Volatility modules.
Tevogen | Cash |
Latest Tevogen Bio's Cash Growth Pattern
Below is the plot of the Cash of Tevogen Bio Holdings over the last few years. Cash refers to the most liquid asset of Tevogen Bio Holdings, which is listed under current asset account on Tevogen Bio Holdings balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Tevogen Bio customers. The amounts must be unrestricted with restricted cash listed in a different Tevogen Bio account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Tevogen Bio's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tevogen Bio's overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Tevogen Cash Regression Statistics
| Arithmetic Mean | 5,348,967 | |
| Geometric Mean | 1,554,441 | |
| Coefficient Of Variation | 59.20 | |
| Mean Deviation | 2,655,293 | |
| Median | 7,119,162 | |
| Standard Deviation | 3,166,737 | |
| Sample Variance | 10T | |
| Range | 7.1M | |
| R-Value | (0.75) | |
| Mean Square Error | 4.7T | |
| R-Squared | 0.57 | |
| Significance | 0.0008 | |
| Slope | (500,358) | |
| Total Sum of Squares | 150.4T |
Tevogen Cash History
Other Fundumenentals of Tevogen Bio Holdings
Tevogen Bio Cash component correlations
Click cells to compare fundamentals
About Tevogen Bio Financial Statements
Tevogen Bio investors utilize fundamental indicators, such as Cash, to predict how Tevogen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cash | 8 K | 7.6 K | |
| Cash And Short Term Investments | 8 K | 7.6 K | |
| Change In Cash | -108.3 K | -102.9 K | |
| Free Cash Flow | -1.6 M | -1.7 M | |
| Begin Period Cash Flow | 148.6 K | 175.1 K | |
| Other Cashflows From Financing Activities | 394.4 M | 414.1 M | |
| Other Non Cash Items | -2 M | -1.9 M | |
| Total Cash From Operating Activities | -1.6 M | -1.7 M | |
| Total Cash From Financing Activities | -307.5 M | -292.1 M | |
| End Period Cash Flow | 8 K | 7.6 K | |
| Other Cashflows From Investing Activities | 308.6 M | 274.3 M | |
| Operating Cash Flow Per Share | (0.01) | (0.01) | |
| Free Cash Flow Per Share | (0.01) | (0.01) | |
| Capex To Operating Cash Flow | (2.56) | (2.43) | |
| EV To Operating Cash Flow | -1.5 K | -1.6 K | |
| EV To Free Cash Flow | -1.5 K | -1.6 K | |
| Price To Operating Cash Flows Ratio | -1.5 K | -1.6 K | |
| Price To Free Cash Flows Ratio | -1.5 K | -1.6 K | |
| Free Cash Flow Operating Cash Flow Ratio | 2.90 | 1.70 | |
| Cash Flow Coverage Ratios | (0.97) | (0.92) | |
| Price Cash Flow Ratio | -1.5 K | -1.6 K | |
| Cash Flow To Debt Ratio | (0.97) | (0.92) |
Pair Trading with Tevogen Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tevogen Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tevogen Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Tevogen Stock
Moving against Tevogen Stock
The ability to find closely correlated positions to Tevogen Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tevogen Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tevogen Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tevogen Bio Holdings to buy it.
The correlation of Tevogen Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tevogen Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tevogen Bio Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tevogen Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Tevogen Bio Correlation against competitors. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tevogen Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tevogen Bio Holdings is measured differently than its book value, which is the value of Tevogen that is recorded on the company's balance sheet. Investors also form their own opinion of Tevogen Bio's value that differs from its market value or its book value, called intrinsic value, which is Tevogen Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tevogen Bio's market value can be influenced by many factors that don't directly affect Tevogen Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tevogen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.